KP Tissue Inc. (KPTSF)
OTCMKTS · Delayed Price · Currency is USD
7.65
-0.06 (-0.78%)
At close: Feb 11, 2026

KP Tissue Statistics

Total Valuation

KP Tissue has a market cap or net worth of 77.29 million.

Market Cap77.29M
Enterprise Value n/a

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date Feb 18, 2026
Ex-Dividend Date Dec 31, 2025

Share Statistics

Current Share Class 10.02M
Shares Outstanding n/a
Shares Change (YoY) +0.26%
Shares Change (QoQ) +0.07%
Owned by Insiders (%) 0.62%
Owned by Institutions (%) 1.05%
Float 9.96M

Valuation Ratios

The trailing PE ratio is 27.68 and the forward PE ratio is 1.23.

PE Ratio 27.68
Forward PE 1.23
PS Ratio n/a
PB Ratio 1.55
P/TBV Ratio 1.55
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.00

Current Ratio 1.00
Quick Ratio 1.00
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 5.55%.

Return on Equity (ROE) 5.55%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 5.94%
Revenue Per Employee n/a
Profits Per Employee 1,034
Employee Count 2,700
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, KP Tissue has paid 40,204 in taxes.

Income Tax 40,204
Effective Tax Rate 1.42%

Stock Price Statistics

The stock price has increased by +37.07% in the last 52 weeks. The beta is 0.31, so KP Tissue's price volatility has been lower than the market average.

Beta (5Y) 0.31
52-Week Price Change +37.07%
50-Day Moving Average 7.11
200-Day Moving Average 7.02
Relative Strength Index (RSI) 62.38
Average Volume (20 Days) 619

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income n/a
Pretax Income 2.83M
Net Income 2.79M
EBITDA n/a
EBIT n/a
Earnings Per Share (EPS) 0.28
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) 49.90M
Book Value Per Share 4.99
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.52, which amounts to a dividend yield of 6.78%.

Dividend Per Share 0.52
Dividend Yield 6.78%
Dividend Growth (YoY) -0.01%
Years of Dividend Growth n/a
Payout Ratio 179.02%
Buyback Yield -0.26%
Shareholder Yield 6.52%
Earnings Yield 3.61%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1